3.475USD-2.80%Mkt Cap: 262.65M USDP/E: —Last update: 2026-06-01
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United …
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap262.65M USD
Enterprise Value174.05M USD
Revenue (TTM)—
Gross Profit-33.35M USD
Net Income (TTM)13.27M USD
Revenue/Share—
Last Price3.475 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees86
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-4.03
PEG—
EV/EBITDA-3.16
EV/Revenue—
P/S—
P/B1.20
EPS (TTM)-0.58
EPS (Forward)-0.89
52W Range
1.60037% of range6.600
52W High6.600 USD
52W Low1.600 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE8.76%
ROA7.68%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-44.78M USD
CapEx (TTM)933.16K USD
FCF Margin—
FCF Yield-11.99%
Net Debt-101.22M USD
Net Debt/EBITDA1.84
Balance Sheet
Debt/Equity0.04
Current Ratio11.45
Quick Ratio11.06
Book Value/Sh3.000 USD
Cash/Share1.404 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJan 5, 2024
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)10.10 USD
Target Range6.000 USD – 15.00 USD
# Analysts10
Ownership
Shares Out.76.46M
Float52.34M
Insiders0.84%
Institutions91.88%
Short Interest
Short Ratio2.8d
Short % Float3.73%
Short % Out.3.59%
Shares Short2.75M
Short (prev mo.)3.00M
Technical
SMA 503.774 (-7.9%)
SMA 2003.412 (+1.8%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)831.85K
Avg Vol (10d)455.66K
Technical Indicators
RSI (14)45.0
MACD-0.0386
MACD Signal-0.0241
MACD Hist.-0.0145
BB Upper4.093 USD
BB Middle3.739 USD
BB Lower3.384 USD
BB Width18.95%
ATR (14)0.2663 USD
Vol Ratio (20d)0.13x